Susana R. K.
- Country
- Spain
- Department
- Oncología
Research Overview
- Evaluation of Safety and Efficacy of Targeted Therapies in Metastatic Colorectal Cancer Subpopulations
- Evaluation of Safety and Efficacy of Novel Targeted Therapy Combinations in Adults with Advanced or Metastatic BRAF V600 Colorectal Cancer
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
Data & Insights
Has run more than one trial at 128 of 287 partner sites.
Specializations
Colorectal Cancer Specialization
The investigator focuses on treating advanced forms of colorectal cancer, with particular emphasis on cases involving specific genetic mutations including BRAF V600E, KRAS G12C, and KRAS/NRAS wild-type variants.
- Metastatic Colorectal Cancer Treatment
- Gene-Targeted Therapies
- Combination Treatment Approaches
Advanced Cancer Management
Expertise extends to treating locally advanced unresectable tumors and developing therapeutic strategies for microsatellite instability high (MSI-H) cancers. The investigator works with novel therapeutic combinations including immunotherapy and targeted biological agents.
- Neoadjuvant Treatment Protocols
- Immunotherapy Applications
- Precision Medicine Approaches
Innovative Treatment Development
The investigator specializes in evaluating novel therapeutic approaches including genetic vaccines and targeted therapy combinations. Their work encompasses the development of treatments for drug-resistant cancers and exploration of new therapeutic agents.
- Novel Drug Evaluation
- Resistance Mechanism Studies
- Combination Therapy Development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.